It’s another setback for a one-dose vaccine
Food and Drug Administration warned fact sheet Johnson & Johnson for COVID-19 vaccine saying the shot may increase the risk of a nerve condition called Guillain-Barré syndrome. The agency says the benefits of the vaccine still outweigh the risks.
The Centers for Disease Control and Prevention said in a statement that nearly 100 cases of the syndrome have been reported in about 12.6 million people who have received the Johnson & Johnson vaccine. To Washington Post. This is a very rare complication, but people who get the shot seem to be nearby. 3 to 5 times Guillain-Barré syndrome is more likely to develop than the general population.
There is no indication that Moderna or Pfizer/BioNTech vaccines carry the same risk.
In Guillain Barre SyndromeThe body’s immune system attacks the nerves. It can cause tingling, weakness and coordination problems in the hands and feet. Most people make a full recovery, but it can cause permanent nerve damage in some cases.
The syndrome has previously been linked to vaccines. America stopped using The swine flu vaccine was reported in 1976 after it was reported that people who took the vaccine developed Guillain-Barré. A few years, a . is small increased risk Of the syndrome with seasonal flu vaccines – usually about one or two additional cases for every 1 million flu shots administered. The CDC notes that people may be more likely to develop Guillain-Barré from the flu than from the flu shot.
This is the second health risk associated with the Johnson & Johnson vaccine. US health agencies recommended stopping administration of the shot in April after it was linked to a rare clotting disorder. The company added a warning about the risk of the disorder, and the pause was lifted after 10 days.
Agencies have not recommended banning the vaccine this time. The vaccine remains available and will only have an additional warning label. People in the United States also have Moderna and Pfizer/BioNTech vaccines.
Experts expected the Johnson & Johnson shot to play a major role in the US vaccination campaign because it only takes one dose instead of the two doses required by Moderna or Pfizer/BioNtech. So far it has been administered less than 10 percent Number of people vaccinated in the US.
The number of people vaccinated every day in the US has fallen to nearly 500,000, down from a peak of nearly 3 million in April. The number of COVID-19 cases is started climbing again As the Delta version takes hold nationwide.